ExSAR Corporation is very pleased to announce the addition of 2 new members to the Board of Directors.   Ray Salemme, PhD and Bob Towarnicki were unanimously approved to join ExSAR's Board and bring with them years of experience and knowledge of the biotech industry.

 

F. Raymond Salemme, PhD is currently the CEO of Redpoint Bio Corp., a biotechnology company and is a founder of Imiplex LLC, a nanotechnology company.

 

Robert Towarnicki is currently the President & CEO of Makefield Therapeutics, an emerging specialty pharmaceutical company developing therapeutics based on its proprietary Hybrid Nanoparticle™ technology platform.